Elgethun Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $72.6M | Buy |
60,510
+9,231
| +18% | +$9.43M | 10.11% | 1 |
|
|
2026
Q1 | $47.2M | Buy |
51,279
+26,639
| +108% | +$27M | 7.8% | 2 |
|
|
2025
Q4 | $26.5M | Buy |
24,640
+1
| +0% | +$956 | 4.57% | 4 |
|
|
2025
Q3 | $19.6M | Buy |
24,639
+2
| +0% | +$1.49K | 3.55% | 5 |
|
|
2025
Q2 | $19.2M | Buy |
24,637
+1
| +0% | +$777 | 3.86% | 5 |
|
|
2025
Q1 | $20.3M | Sell |
24,636
-54
| -0.2% | -$44.9K | 4.55% | 4 |
|
|
2024
Q4 | $19.1M | Buy |
24,690
+56
| +0.2% | +$46.4K | 4.63% | 3 |
|
|
2024
Q3 | $21.8M | Buy |
24,634
+1
| +0% | +$899 | 5.12% | 3 |
|
|
2024
Q2 | $22.3M | Buy |
24,633
+1,092
| +5% | +$874K | 5.62% | 3 |
|
|
2024
Q1 | $17.9M | Buy |
23,541
+11,620
| +97% | +$8.27M | 4.5% | 3 |
|
|
2023
Q4 | $6.95M | Buy |
11,921
+5
| +0% | +$2.92K | 1.97% | 14 |
|
|
2023
Q3 | $6.36M | Buy |
11,916
+2,750
| +30% | +$1.42M | 1.92% | 16 |
|
|
2023
Q2 | $4.29M | Hold |
9,166
| – | – | 1.29% | 25 |
|
|
2023
Q1 | $3.18M | Hold |
9,166
| – | – | 1.01% | 35 |
|
|
2022
Q4 | $3.32M | Hold |
9,166
| – | – | 1.2% | 31 |
|
|
2022
Q3 | $2.96M | Hold |
9,166
| – | – | 1.18% | 28 |
|
|
2022
Q2 | $2.97M | Hold |
9,166
| – | – | 1.15% | 28 |
|
|
2022
Q1 | $2.63M | Hold |
9,166
| – | – | 0.89% | 37 |
|
|
2021
Q4 | $2.46M | Hold |
9,166
| – | – | 0.86% | 41 |
|
|
2021
Q3 | $2.12M | Hold |
9,166
| – | – | 0.73% | 42 |
|
|
2021
Q2 | $2.1M | Hold |
9,166
| – | – | 0.72% | 41 |
|
|
2021
Q1 | $1.71M | Hold |
9,166
| – | – | 0.67% | 38 |
|
|
2020
Q4 | $1.55M | Hold |
9,166
| – | – | 0.66% | 38 |
|
|
2020
Q3 | $1.36M | Hold |
9,166
| – | – | 0.74% | 35 |
|
|
2020
Q2 | $1.5M | Hold |
9,166
| – | – | 0.88% | 34 |
|
|
2020
Q1 | $1.27M | Hold |
9,166
| – | – | 0.71% | 38 |
|
|
2019
Q4 | $1.21M | Hold |
9,166
| – | – | 0.59% | 37 |
|
|
2019
Q3 | $1.02M | Hold |
9,166
| – | – | 0.55% | 39 |
|
|
2019
Q2 | $1.02M | Hold |
9,166
| – | – | 0.55% | 38 |
|
|
2019
Q1 | $1.19M | Hold |
9,166
| – | – | 0.69% | 40 |
|
|
2018
Q4 | $1.05M | Hold |
9,166
| – | – | 0.73% | 39 |
|
|
2018
Q3 | $986K | Hold |
9,166
| – | – | 0.64% | 44 |
|
|
2018
Q2 | $783K | Sell |
9,166
-1,250
| -12% | -$103K | 0.55% | 50 |
|
|
2018
Q1 | $806K | Hold |
10,416
| – | – | 0.56% | 50 |
|
|
2017
Q4 | $880K | Hold |
10,416
| – | – | 0.62% | 44 |
|
|
2017
Q3 | $891K | Hold |
10,416
| – | – | 0.65% | 41 |
|
|
2017
Q2 | $857K | Hold |
10,416
| – | – | 0.67% | 40 |
|
|
2017
Q1 | $876K | Hold |
10,416
| – | – | 0.7% | 40 |
|
|
2016
Q4 | $766K | Buy |
+10,416
| New | +$776K | 0.6% | 42 |
|
Other funds holding LLY
SC
ONB
GIM
Elgethun Capital Management's LLY Position: Q2 2026 in Review
Elgethun Capital Management increased its Eli Lilly (LLY) stake by 18% in Q2 2026, buying an estimated $9.43M and bringing the position to 60,510 shares worth $72.6M. The position accounts for 10.11% of the portfolio, ranked #1.
Elgethun Capital Management first reported a position in LLY in Q4 2016 and has held it in 39 quarters since. 1,976 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Elgethun Capital Management held 60,510 shares of Eli Lilly worth $72.6M as of Q2 2026.
- Elgethun Capital Management bought 9,231 Eli Lilly shares in Q2 2026, an estimated $9.43M.
- Eli Lilly made up 10.11% of Elgethun Capital Management's portfolio in Q2 2026, its #1 holding.
- Elgethun Capital Management first reported a position in Eli Lilly in Q4 2016 and has held it in 39 quarters since.
- 1,976 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Elgethun Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.